The efficacy and functions of Duvelisib capsules

Duvelisib (Duvelisib) is an anti-cancer drug that targets the leukocyte signaling pathway and is mainly used to treat specific types of lymphoma and leukemia. Its mechanism of action and efficacy have attracted widespread attention in the field of cancer treatment. Duveliced u200bu200bhas been approved for the treatment of chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). The application of duvelised can improve disease control, slow down disease progression, improve patients' progression-free survival (PFS) and improve clinical response rates. PFS is a key indicator of treatment effectiveness, which reflects the time that patients do not experience disease progression.